Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child–Pugh grade correlated with prognosis after transarterial chemoembolization

被引：3
|
作者：
Koichiro Yamakado
Shiro Miyayama
Shozo Hirota
Kimiyoshi Mizunuma
Kenji Nakamura
Yoshitaka Inaba
Hiroaki Maeda
Kunihiro Matsuo
Norifumi Nishida
Takeshi Aramaki
Hiroshi Anai
Shinichi Koura
Shigeo Oikawa
Ken Watanabe
Taku Yasumoto
Kinya Furuichi
Masato Yamaguchi
机构：
[1] Mie University,Department of Interventional Radiology, School of Medicine
[2] Fukui-ken Saiseikai Hospital,Department of Diagnostic Radiology
[3] Hyogo College of Medicine,Department of Radiology
[4] Ohtawara Red Cross Hospital,Department of Radiology
[5] Daito Central Hospital,Department of Radiology
[6] Aichi Cancer Center Hospital and Research Institute,Department of Diagnostic and Interventional Radiology
[7] Narumi Hospital,Department of Radiology
[8] Osaka City University,Department of Radiology
[9] Shizuoka Cancer Center,Department of Diagnostic Radiology
[10] Nara Medical University,Department of Radiology
[11] Fukuoka University,Department of Radiology
[12] Iwate Prefectural Central Hospital,Department of Radiology
[13] Jikei University,Department of Radiology
[14] Toyonaka Municipal Hospital,Department of Radiology
[15] Higashiosaka City General Hospital,Department of Radiology
[16] Kobe University,Department of Radiology
来源：
Japanese Journal of Radiology | 2014年 / 32卷
关键词：
Hepatocellular carcinoma; Arterial embolization; Prognosis; Child–Pugh grade; Tumor number; Tumor diameter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：260 / 265
页数：5
相关论文
共 50 条
  • [41] Should transarterial chemoembolization be continued after non-response to the first two sessions for intermediate-stage hepatocellular carcinoma?
    Chen, S.
    Peng, Z.
    Chen, M.
    Feng, S-T.
    Kuang, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
    Zheng, Yitao
    Xiang, Yanjun
    Shi, Hongqi
    Lin, Zhuoqun
    Cheng, Shuqun
    Zhu, Jiuting
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1079 - 1093
  • [43] Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
    Sacco, Rodolfo
    Antonucci, Michela
    Bargellini, Irene
    Marceglia, Sara
    Mismas, Valeria
    Cabibbo, Giuseppe
    FUTURE ONCOLOGY, 2015, 11 (17) : 2371 - 2373
  • [44] Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)
    Fernandez-Palanca, Paula
    Mauriz, Jose L.
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (02)
  • [45] Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (SPACE)
    Lencioni, R.
    Zou, J.
    Leberre, M.
    Meinhardt, G.
    Voliotis, D.
    Bruix, J.
    Llovet, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma
    Xiang, Yan-Jun
    Wang, Kang
    Yu, Hong-Ming
    Li, Xiao-Wei
    Cheng, Yu-Qiang
    Wang, Wei-Jun
    Feng, Jin-Kai
    Bo, Meng-Han
    Qin, Ying-Yi
    Zheng, Yi-Tao
    Shan, Yun-Feng
    Zhou, Li-Ping
    Zhai, Jian
    Cheng, Shu-Qun
    HEPATOLOGY RESEARCH, 2022, 52 (08) : 721 - 729
  • [47] Transarterial- chemoembolization remains an effective therapy for intermediate-stage hepatocellular carcinoma with preserved liver function
    Saito, Natsuhiko
    Tanaka, Toshihiro
    Nishiohuku, Hideyuki
    Sato, Takeshi
    Masada, Tetsuya
    Matsumoto, Takeshi
    Anai, Hiroshi
    Sakaguchi, Hiroshi
    Sueyoshi, Satoru
    Marugami, Nagaaki
    Kichikawa, Kimihiko
    HEPATOLOGY RESEARCH, 2020, 50 (10) : 1176 - 1185
  • [48] THE COMPARISON BETWEEN OVERALL SURVIVAL OF TRANSARTERIAL CHEMOEMBOLIZATION AND BEST SUPPORTIVE CARE IN INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
    Akarapatima, Keerati
    Chang, Arunchai
    Prateepchaiboon, Tanaporn
    Pungpipattrakul, Nuttanit
    Songjamrat, Apiradee
    Pakdeejit, Songklod
    Rattanasupar, Attapon
    GUT, 2021, 70 : A73 - A74
  • [49] Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma
    Peng, Zhenwei
    Chen, Shuling
    Xiao, Han
    Wang, Yu
    Li, Jiaping
    Mei, Jie
    Chen, Zebin
    Zhou, Qian
    Feng, Shiting
    Chen, Minshan
    Qian, Guojun
    Peng, Sui
    Kuang, Ming
    RADIOLOGY, 2019, 292 (01) : 237 - 247
  • [50] Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
    Koroki, Keisuke
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maruta, Susumu
    Maeda, Takahiro
    Yokoyama, Masayuki
    Wakamatsu, Toru
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Kanogawa, Naoya
    Saito, Tomoko
    Kondo, Takayuki
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Jun
    Kuboki, Satoshi
    Ohtsuka, Masayuki
    Miyazaki, Masaru
    Yokosuka, Osamu
    Kato, Naoya
    LIVER CANCER, 2020, 9 (05) : 596 - 612
12345